<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-cyanocobalamin.xml</id>
  <title>Recalls Watch: Cyanocobalamin</title>
  <link rel="self" href="https://recalls.watch/feed/substance-cyanocobalamin.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-11-11T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/100204/</id>
    <title>American Health Packaging: Cyanocobalamin Injection</title>
    <link href="https://recalls.watch/recall/fda/100204/"/>
    <updated>2026-11-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99867/</id>
    <title>Carolina Infusion, LLC: TIRZEPATIDE 26 MG/ML INJECTABLE and 15 more</title>
    <link href="https://recalls.watch/recall/fda/99867/"/>
    <updated>2026-10-14T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. Lack of Assurance of Sterility: Related to processing equipment used in compounded product.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99503/</id>
    <title>American Regent, Inc.: Nitroglycerin injection and 11 more</title>
    <link href="https://recalls.watch/recall/fda/99503/"/>
    <updated>2026-08-26T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98646/</id>
    <title>PAYLESS COMPOUNDERS, LLC: Semaglutide-Glycine-Cyanocobalamin Injectable</title>
    <link href="https://recalls.watch/recall/fda/98646/"/>
    <updated>2026-04-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97292/</id>
    <title>AEQUITA PHARMACY: Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol and 12 more</title>
    <link href="https://recalls.watch/recall/fda/97292/"/>
    <updated>2025-08-13T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Processing Controls.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96742/</id>
    <title>Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado): Methylcobalamin Injectable and 13 more</title>
    <link href="https://recalls.watch/recall/fda/96742/"/>
    <updated>2025-07-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95190/</id>
    <title>ProRx LLC: Semaglutide and 6 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95190"/>
    <updated>2024-09-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94914/</id>
    <title>Zydus Pharmaceuticals (USA) Inc: Cyanocobalamin Injection</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94914"/>
    <updated>2024-07-24T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of particulate matter: glass</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94842/</id>
    <title>Accord Healthcare, Inc.: Dodex Injectable</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94842"/>
    <updated>2024-07-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent drug: out of specification results</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/89909/</id>
    <title>TMC Acquisition LLC dba Tailor Made Compounding: Alpha Lipoic Acid 25mg/mL and 51 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=89909"/>
    <updated>2022-07-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/65360/</id>
    <title>Lowlite Investments, Inc. D/B/A Olympia Pharmacy: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml and 104 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=65360"/>
    <updated>2013-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes</summary>
  </entry>
</feed>
